$62.35
▲ +0.0% Today
as of Jul 22, 16:46 ET
Last 30 days
Recent Press Releases & News
BALL: Raising target price to $69.00
Zacks.com featured highlights include NVIDIA, Neurocrine Biosciences and Ball
What to Expect From Ball Corporation’s Next Quarterly Earnings Report
Overview
52-week range
$45
$68
75% of range
Avg surprise (last 3)
+8.1%
Avg reaction (last 2)
-3.3%
0% positive
Latest IV / EM
31%
EM ±7.1% · $63 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $0.94 | $0.85 | +10.6% | +23.7% | -6.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $1.18 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $0.90 | $0.87 | +3.5% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $0.76 | $0.69 | +10.1% | — | -0.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.65 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.51 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $11.61 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.64 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.55 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | BMO | $0.99 | $0.90 | +10.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | — | — | — | — | — | — | — | — |
| EPS (diluted) | $0.77 | — | $1.18 | $0.76 | $0.63 | — | $0.65 | $0.51 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $730M | $1.21B | $568M | $296M | $449M | $885M | $1.44B | $1.35B |
| Inventory | $2.22B | $2.01B | $1.86B | $1.73B | $1.64B | $1.48B | $1.39B | $1.43B |
| Total current assets | $6.22B | $6.11B | $5.35B | $5.25B | $5.04B | $4.84B | $5.61B | $5.75B |
| Total assets | $19.77B | $19.52B | $18.72B | $18.61B | $18.04B | $17.63B | $18.82B | $18.96B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $14.15B | $14.10B | $13.27B | $13.33B | $12.47B | $11.70B | $12.07B | $11.98B |
| Total equity | $5.60B | $5.42B | $5.45B | $5.21B | $5.50B | $5.86B | $6.68B | $6.91B |